GlaxoSmithKline Consumer Healthcare Pakistan Limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was PKR 6,079.6 million compared to PKR 5,281.07 million a year ago. Net income was PKR 363.89 million compared to PKR 295.96 million a year ago. Basic earnings per share from continuing operations was PKR 3.11 compared to PKR 2.53 a year ago. For the nine months, sales was PKR 18,002.45 million compared to PKR 14,489.45 million a year ago. Net income was PKR 1,642.62 million compared to PKR 979.56 million a year ago. Basic earnings per share from continuing operations was PKR 14.03 compared to PKR 8.37 a year ago.